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Abstract CMV RNAs 1 and 2 are considered to constitute the 
viral replicon. Tobacco plants were transformed with either 
RNA1 or RNA2 to produce plant lines VI and V2, respectively. 
Plants homozygous for each of the RNAs were generated and 
crossed to produce V1 V2 (V2V1) lines that expressed both RNA 1 
and RNA2. An RNase protection assay indicated that RNA1 and 
RNA2 multiplied in V1V2 (V2V1) plants. Surprisingly, V1V2 
(V2V1) plants, unlike their parent lines, showed a remarkably 
high level of resistance to CMV; this resistance was more effec- 
tive against RNA inoculation than against virion inoculation. 
Experiments using protoplasts showed that the resistance was 
expressed at the single cell level. All the data together suggested 
that the observed resistance does not fit the criteria for either 
'RNA-mediated' or 'replicase-mediated' resistance. 
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1. Introduction 
Cucumber mosaic virus (CMV) possesses a genome consist- 
ing of three plus-sense, single-stranded RNA molecules, desig- 
nated RNA1, RNA2 and RNA3 in decreasing order of molec- 
ular weight. The la protein and 2a protein encoded by RNAI  
and RNA2, respectively, are necessary for viral replication 
[1,2]. The 3a protein encoded by RNA3 is involved in virus 
movement, and a subgenomic RNA,  RNA4, which is generated 
from the 3' half of RNA3 serves as a messenger RNA for the 
viral coat protein. 
CMV disease wreaks such enormous damage on agricultural 
crop production throughout he world that significant efforts 
have been made to create CMV-resistant plants by classical 
breeding techniques. There are now a number of studies that 
describe the establishment of CMV resistance in transgenic 
plants. For example, transgenic plants that express the CMV 
coat protein gene are often virus resistant [3,4], and plants 
highly resistant o CMV infection can be generated by express- 
ing non-structural genes such as gene 2a [5-7]. This kind of 
resistance is called 'pathogen-derived' resistance. Recent exper- 
iments using other viruses suggest hat transgenes expressing 
untranslatable sense RNAs can confer effective resistance; this 
is called 'RNA-mediated'  or 'homology-dependent' resistance 
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We obtained transgenic tobacco plants that simultaneously 
expressed intact forms of RNA1 and RNA2, and we expected 
that all the transformed cells from these plants would contain 
infectious RNA1 and RNA2. We also expected that these 
plants would support CMV RNA3 replication, instead we ob- 
served a high degree of resistance to CMV in these plants. The 
mechanism for the observed resistance seemed to be different 
from that of the resistance which have been reported as ~repli- 
case-mediated' [5,6] or 'RNA-mediated'.  This resistance and its 
relation to the ratio of accumulation of each of the viral RNAs 
during the establishment of CMV infection is discussed. 
2. Materials and methods 
2.1. Construction oJ'a plant expression veetor and generation q]' 
transgenic plants 
Cauliflower mosaic virus 35S promoter in a plant expression vector, 
pBIl21 (Clontech), was subcloned between the HindIII and BamHl 
sites of pUC118 (Takara Shuzo, Japan). Oligonucleotide-directed mut- 
agenesis was used to create a Stul site at the transcription start site of 
the promoter [13]. A fragment containing the entire cDNA clone of 
RNAI of CMV-Y, which was prepared by PstI digestion and T4 DNA 
polymerase treatment followed by SacI digestion of pCY1-T7KP [14], 
was inserted between the StuI and Saci sites of the modified vector. 
After double digestion with HindIII and Sacl, the 4.1 kb fragment 
containing the cDNA of RNA1 and the 35S promoter egion was 
cloned between the HindIII and SacI sites of pBIl21 (Fig. 1). For 
convenience, the 5' half of the RNA2 cDNA clone from CMV-Y (a 
BamHI HindIII fragment ofpCY2-T7 [14]) and the 3' halfofpCY2-T7 
(a HindIII SacI fragment) were ligated to create intact RNA2 after 
insertion between the BamHI and SacI sites of the modified vector. This 
construct contained a T7 promoter egion upstream of the cDNA of 
RNA2. The T7 promoter region of pCY2-T7 was deleted by oligonucle- 
otide-directed mutagenesis so that the viral 5' end sequence could be 
linked at the transcription site of the 35S promoter. The recombinant 
plant expression vectors were introduced into Agrobacterium tum~fa- 
ciens LBA 4404 which was used to transform tobacco (Nieotiana taba- 
cum cv. BY-4) by the leaf disk method [15]. Plants transformed with 
either RNA1 or RNA2 were designated V1 and V2, respectively. The 
homozygous R 2 generations ofthe self-fertilized transgenic plants were 
crossed with each other to produce plants expressing both RNAI and 
RNA2; these progeny plants were designated V 1 V2 or V2V 1 depending 
on the maternal plant line. 
2.2. PCR analysis of transgene 
DNA samples were prepared from total nucleic acids extracted from 
tobacco plants by LiC1 precipitation [14]. Each sample (0.5 ktg) was 
subjected to PCR using an LA PCR Kit (Takara Shuzo). Three syn- 
thetic oligonucleotides were used as primers: 5'-GTTCAATACACCA- 
CAGTACTCGTAGCGG-3" (complementary to the region from posi- 
tions 3019 to 3046 of RNA1), 5'-ATAGCAATACTGCCAACTCAG- 
CTCC-3' (complementary to the region from positions 2792 to 2816 of 
RNA2) and 5"-GGATCTAACAGAACTCGCCG-3" (about 500 nucle- 
otides upstream from the transcription start site for the 35S promoter). 
The PCR lasted for thirty cycles of amplification with the following 
parameters: denaturation at98°C for 15 s, annealing at 62°C for 15 s, 
and synthesis at 68°C for 5 min. 
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2.3. RNase proteetion assay 
The following restriction fragments of pCYI-T7 and pCY2-T7 [14] 
cDNA were subcloned into pBluescript II SK(-) and KS(-) (Strat- 
agene), respectively, to generate 32p-labeled antisense transcripts used 
as probes for RNase protection assay: (i) XbaI-EcoRI fragment (from 
nucleotide positions 382 to 851 in cDNA of RNAI). (ii) SalI-EcoRV 
fragment (from nucleotide positions 145 to 598 in cDNA of RNA2). 
The resultant plasmids containing DNA fragments for RNA1 and 
RNA2 were linearized with XbaI and XhoI, respectively, and tran- 
scribed with T7 RNA polymerase containing [~-32P]UTR The specific 
activity of RNA probes was 1 x 108 to 2 x 108 cpm//,tg. Guardian RNase 
Protection Assay Kit (Clontech) was used essentially as described [16]. 
Total nucleic acids were isolated from leaf tissue by the guanidinium 
i sothiocyanate extraction followed by phenol/chloroform (1:1) extrac- 
tion, and total RNAs were precipitated by LiCI as described [14]. Ten 
¢tg of RNA samples were mixed with the ~2p-labeled riboprobes. The 
mixed samples were treated with RNase mixture (1 : 1000) at 45°C for 
12 h, precipitated by ethanol, and then electrophoresed in a 4% poly- 
acrylamide-8 M urea gel. After drying, the gel was exposed to X-ray 
film. 
2.4. Whole-plant inoeulation experiments 
CMV-Y has been maintained in our laboratory. Viral RNA was 
extracted as described previously [17]. Plants were dusted with carbo- 
rundum, rub-inoculated with virus or viral RNA, and maintained in a 
greenhouse at25 26°C under natural light conditions. Symptoms were 
noted about 1 month after inoculation. 
2.5. Protoplast experiments 
Preparation of protoplasts from transgenic and non-transgenic to- 
bacco leaf tissue was described previously [18]. Virus and viral RNA 
were introduced into protoplasts in the presence of polyethylene glycol 
(PEG) and CaC12 [19]. Infected protoplasts were analyzed by Northern 
blot analysis. The inoculated protoplasts were stained with fluorescent 
polyclonal antibody against CMV-Y after incubation for 24 h at 28°C 
under continuous illumination with fluorescent lamps [20]. To evaluate 
the viral replication in the protoplasts, total RNAs were extracted from 
2 × l0  4 protoplasts that had been incubated for 24 h. The samples were 
treated with buffer containing formaldehyde and formamide ssentially 
as described previously [21]. The samples were then electrophoresed on 
a 1.5% agarose gel containing 0.66 M formaldehyde, transferred to a 
nitrocellulose membrane and hybridized with 32p-labeled mixed probes. 
The probes were a mixture of following fragments: the 1,770 bases 
between the two XhoI sites of RNA1, the 1,750 bases between the SalI 
and HindII1 sites of RNA2, and the 1,870 bases between the two StyI 
sites of RNA3. The probes were synthesized by the random primed 
method using a Prime-It II random primer labeling kit (Stratagene). 
3. Results and discussion 
3.1. Transgenic plants 
The constructs of transgenes used in this study are shown in 
Fig. 1. Five V1 lines (R0) transformed with the cDNA of RNAI  
were obtained; only one V1 line contained a single T-DNA 
insertion as judged from the segregation data of the R~ lines for 
kanamycin resistance. Six V2 (R0) lines that were transformed 
with the cDNA of RNA2 were obtained; all the lines contained 
single T-DNA insertions. We have selected the transgenic lines 
harboring only a single cDNA copy so that the transgenic 
plants (R~) homozygous for each of the cDNA of RNA1 and 
RNA2 should be easily selected based on the segregation data. 
The plants that were homozygous for the cDNAs of RNA1 and 
for RNA2 were crossed to generate V1V2 (V2V1), the plants 
which contained cDNA copies of both RNA1 and RNA2. The 
integration of the cDNAs from the respective viral RNAs into 
V1, V2, V1V2 and V2V1 plants was confirmed by PCR, by 
which the expected DNA fragments with almost full-length 
cDNA from RNA1 and RNA2 were amplified in all the prep- 
arations from the plants containing the transgenes (data not 
shown). 
3.2. Transgene xpression 
When V I plants were inoculated with in vitro synthesized 
RNA2 and RNA3, and when V2 plants were inoculated with 
in vitro synthesized RNA1 and RNA3, we observed typical 
CMV disease symptoms on those transgenic plants. The inocu- 
lation experiments showed that biologically active RNA1 and 
RNA2 molecules were actually generated from the correspond- 
ing transgenic plants. Although V1, V2 and V1V2 (V2V1) Rj 
plants were initially examined for transgene expression by 
Northern blot analysis, the RNA bands with the expected sizes 
in V1 and V2 plants were hardly detected; but we observed faint 
bands in VIV2 and V2V1 plants. To determine the extent of 
accumulation of the expected transgene, we used an RNase 
protection assay, which is thought to be more sensitive than 
Northern analysis. As shown in Fig. 2, after RNase treatment 
the expected 469-nt and 453-nt bands for RNAI  and RNA2, 
respectively, were readily detected in the corresponding trans- 
genic plants. In addition, the V1V2 (V2VI) plants contained 
bands that were more than 20-fold stronger than those detected 
in the preparations from their parents, suggesting that RNA1 
and RNA2 had actually multiplied in the plants as a replicon. 
We do not know why the accumulation of the transgene tran- 
scripts were so low in the V1 and V2 plant lines. 
3.3. Resistance against CMV infection 
Transgenic plants were screened for viral resistance by me- 
chanical inoculation with CMV virions or with CMV RNA 
(Table 1). Plants were monitored daily for the appearance of 
symptoms and scored one month after inoculation. The V1 V2 
Table 1 
Assessment of resistance to CMV infection in transgenic tobacco plants 
Inoculum concentration (,ug/ml) 
CMV-Y virion CMV-Y RNA 
Line 0.2 0.5 1.0 2.0 5.0 0.2 0.5 1.0 2.0 5.0 10.0 50 100 200 
VIV2 2/10 ~ 9/20 19/26 9/9 5/5 nt 0/5 
V2V1 2/9 8/20 15/25 10/10 5/5 nt 0/5 
BY-4 6/12 10/10 31/31 12/12 2/2 3/12 10/10 
VI nt b 11/11 15/15 nt nt nt 6/7 
V2 nt 9/10 15/15 nt nt nt 6/7 
1/8 1/17 7/17 6/13 4/10 8/9 2/2 
1/8 1/16 4/17 5/13 2/4 4/8 5/5 
8/8 15/15 15/15 4/4 2/2 4/4 nt 
17/17 nt 10/10 nt nt nt nt 
17/17 nt 10/10 nt nt nt nt 
~Number of infected plants/number of inoculated plants. 
bnt, not tested. 
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Fig. I. Schematic representation f the gene constructs for CMV RNA1 and RNA2 used for tobacco transformation. The full-length cDNA clones 
of CMV RNA1 and RNA2 were inserted in expression cassettes in a binary vector, pBIl21. NPTII refers to neomycin phosphotransferase II, 35S 
promoter to the 35S RNA promoter of cauliflower mosaic virus, NOS ter to the transcriptional terminator of nopaline synthase gene. 
and V2V1 lines displayed some resistance toCMV while the VI 
and V2 plants were all susceptible at concentrations of >1.0 
¢tg/ml. Resistance was especially effective against inoculation 
with CMV RNA, and there was a marked elay in the appear- 
ance of systemic symptoms in V1V2 and V2V1 plants. 
To determine if resistance is expressed at the single cell level, 
tobacco mesophyll protoplasts from the CMV-resistant trans- 
genic plants were inoculated with CMV virions or CMV RNA. 
After incubation for 24 h, protoplasts were stained with fluores- 
cent antibody against CMV. Total RNA was subjected to 
Northern blot analysis using 3zp-labeled probes that consisted 
of mixed RNA1, RNA2 and RNA3 fragments. As shown in 
Table 2, a marked suppression of CMV replication was ob- 
served after the inoculations not only with viral RNA but also 
with virions. The levels of CMV RNAs were also very low in 
RNA extracted from the CMV-inoculated protoplasts of the 
transgenic plants (V1V2, V2VI) whether the inoculum was vir- 
ions or RNA (Fig. 3). These results suggested that resistance 
also occurred at the single cell level. This high level of resistance 
observed at the single cell level seemed to be different from the 
results observed in the intact plants inoculated with CMV vir- 
ions. 
3.4. Possible mechanisms Jor resistance 
The integration of mutated replicase genes of CMV leads to 
a high level of resistance against CMV inoculation with virions 
and RNA; this type of 'pathogen-derived' resistance is espe- 
cially called 'replicase-mediated' resistance [5,6]. The exact 
mechanism for this resistance remains unclear; however, it is 
generally thought hat the synthesis of mutated viral replicase 
will interfere with normal interaction between virus and host. 
The resistance induced in this mode seems to be expressed only 
against the virus from which the transgene originated or against 
closely related viruses. In their previous papers describing this 
resistance, the authors found a correlation between the expres- 
sion level of the transgene and the level of resistance [6]. How- 
ever, recent studies uggest that there is no apparent relation- 
ship between resistance and the accumulation f transcripts or 
protein products of the transgene; resistance may, therefore, be 
RNA-mediated [9,12]. In a very recent report, Mueller et al. 
insisted that the so-called 'replicase-mediated' r sistance should 
be grouped with the 'homology-dependent' resistance, which is 
RNA mediated [10]. The theory for the 'RNA-mediated' resist- 
ance is that transgene mRNA levels exceeding a certain thresh- 
old level activate the cytoplasmic machinery that targets the 
mRNAs for inactivation, possibly by RNA degradation, in a 
sequence specific manner. In V IV2 (V2V1) plants, 'RNA-medi- 
ated' resistance may have been triggered by amplification of 
CMV RNA1 and RNA2, which eventually exceeded the thresh- 
A B 
1 2 3 4 5 6 1 2 3 4 5 6 
Fig. 2. RNase protection assay on expression fthe transgene in trans- 
genic plants. 32p-labeled riboprobes complementary to RNA1 (A) and 
RNA2 (B) were hybridized to total RNA extracted from the transgenic 
plants, and subjected toRNase digestion. Lane 1, the undigested ribo- 
probes: lanes 2-5, total RNA from the transgenic plant lines V1, V2, 
V1V2 and V2VI, respectively; ane 6, total RNA from the nontrans- 
formed BY-4 plants. The expected signal was detected (arrowheads). 
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old as a result of replication of RNAI  and RNA2. However, 
we think this resistance seems to be different from the 'repli- 
case-mediated' and even 'RNA-mediated'  resistance in several 
aspects. First, the CMV-resistant ransgenic plants (V1V2 and 
V2V1) contained 20-fold more RNA1 and RNA2 than the 
susceptible transgenic lines (V1 and V2) that contained a very 
low amount of transgene transcripts. If the detected amounts 
of RNAI  and RNA2 in the VIV2 (V2V1) plants were much 
lower, an 'RNA-mediated'  resistance mechanism might seem 
more feasible. Secondly, the transgenic plants exhibited a 
higher resistance when inoculated with RNA than with virions. 
If this is 'RNA-mediated' ,  the resistance must be equally effec- 
tive against inoculation with both CMV virions and CMV 
RNA. Thirdly, V1V2 (V2V1) plants were also resistant against 
the C strain of tomato aspermy virus (C-TAV), which is a 
distantly related virus to CMV (data not shown), and thus the 
resistance was not strictly sequence specific. Even though the 
resistance is 'RNA-mediated'  or 'replicase-mediated', it should 
be sequence specific. Perhaps, in addition to 'RNA-mediated'  
resistance, another mechanism ay exist. Taken together, these 
observations have led us to describe a new mechanism for the 
resistance observed in this paper. A plausible hypothesis is that 
very high level accumulation of RNA1 and RNA2 may affect 
the rate of encapsidation of RNA3 and RNA4; preexisting 
RNAI  and RNA2 might capture the newly synthesized coat 
proteins from RNA4 soon after they were produced, and 
genomic RNA3 and RNA4 would be subject to RNase attack 
before it could be encapsidated by a now depleted population 
of coat proteins. The observation in the protoplast experiment 
also supports this idea. After protoplast preparations, the cells 
must be surrounded by an increased level of RNase activity 
[22]. When the protoplasts are inoculated either with RNA or 
virions, the viral RNAs will be degraded before establishment 
of infection unless they are encapsidated as quickly as possible. 
We speculate that the inoculated viral RNAs were more easily 
degraded in the protoplasts than in the cells of the intact plant 
because the scavenging of coat protein by RNA1 and RNA2 
will accelerate degradation of RNA3 and RNA4 from the chal- 
lenge RNA whether or not the source of the challenge RNA 
was from inoculation with virion or RNA.  
In summary, for our functional analysis of the CMV repli- 
con, we inserted intact forms of viral RNAs in plant genomes. 
Table 2 
Susceptibility of protoplasts i olated from tobacco plants to infection 
with CMV, CMV RNA and TMV RNA 
Inoculum % fluorescent cells" 
(ug/ml) 
CMV Virion CMV RNA 
20 40 100 5 l0 40 
TMV RNA 
Exp. l 
BY-4 
V1V2 
V2V 1 
Exp. 2 
BY-4 
V1V2 
V2V1 
38.2 42.2 53.6 51.5 66.7 
2.8 1.4 0 0 55.9 
1.9 0.8 0 1.9 51.5 
26.0 29.5 49.9 62.7 
0 0 0.5 1.1 
0.2 0.5 0.2 0.6 
~Protoplasts were treated with the fluorescent antibody against CMV 
or tobacco mosaic virus (TMV) 24 h post inoculation and not fewer 
than 200 protoplasts were counted in each experiment. To check the 
transgenic plants are effective against a different virus, TMV was used 
as a control; note that no resistance was observed. 
RNA RNA Vrion Vrion 
10iig/ml 40~.g/ml 40~Lg/ml 100~tg/ml 
I I l I I I I I 
RNA1 --'. 
RNA2 / 
RNA3 / 
RNA4~ 
Fig. 3. Northern blot analysis of CMV RNAs in the infected proto- 
plasts expressing the transgenes. Isolated mesophyll protoplasts were 
inoculated with CMV virions or with CMV RNA. After 24 h incuba- 
tion, total RNA was extracted and examined for viral replication. The 
lanes labeled as CMV RNA and Mock contain 12.5 ng ofCMV RNA 
and RNA from mock-inoculated BY-4 protoplasts, respectively. The 
inoculum concentrations and the inoculated plant lines are presented 
above each lane. Note that CMV RNA was hardly detected in the 
transgenic protoplasts. 
Beyond our expectations, we observed the occurrence of re- 
sistance that could not be necessarily explained by the existing 
proposed mechanisms for engineered resistance against plant 
viruses. Although we considered a possible hypothesis for the 
new resistance, much remains to be understood about how it 
affects the basic features of viral infection such as regulation 
(switch) of replication, translation and encapsidation, 
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